ATP2C2
Basic information
Region (hg38): 16:84368527-84464187
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATP2C2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 26 | 11 | 37 | |||
missense | 125 | 13 | 13 | 151 | ||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 1 | 8 | 3 | 12 | ||
non coding | 10 | |||||
Total | 0 | 0 | 126 | 46 | 28 |
Variants in ATP2C2
This is a list of pathogenic ClinVar variants found in the ATP2C2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-84368623-A-G | not specified | Uncertain significance (Jun 07, 2023) | ||
16-84368651-A-T | not specified | Uncertain significance (Jun 05, 2024) | ||
16-84368656-G-A | not specified | Uncertain significance (Feb 06, 2023) | ||
16-84368670-G-A | not specified | Uncertain significance (Oct 02, 2023) | ||
16-84368680-A-G | ATP2C2-related disorder | Likely benign (Dec 27, 2022) | ||
16-84368710-C-G | not specified | Uncertain significance (Aug 17, 2021) | ||
16-84398553-C-T | ATP2C2-related disorder | Likely benign (Jun 06, 2019) | ||
16-84398569-C-T | not specified | Uncertain significance (Jun 02, 2023) | ||
16-84398570-G-C | ATP2C2-related disorder | Likely benign (Oct 30, 2018) | ||
16-84405153-A-T | not specified | Conflicting classifications of pathogenicity (Jan 18, 2024) | ||
16-84405187-C-G | ATP2C2-related disorder | Likely benign (Aug 29, 2019) | ||
16-84405214-C-T | ATP2C2-related disorder | Likely benign (Mar 20, 2019) | ||
16-84405215-G-A | not specified | Uncertain significance (Jan 03, 2022) | ||
16-84405221-G-A | Conflicting classifications of pathogenicity (Mar 01, 2023) | |||
16-84408400-T-G | Likely benign (Jun 06, 2018) | |||
16-84408455-C-A | Likely benign (Mar 01, 2023) | |||
16-84408489-G-A | Benign (Dec 31, 2019) | |||
16-84410590-T-C | not specified | Uncertain significance (Jul 08, 2022) | ||
16-84410598-A-T | not specified | Uncertain significance (Mar 24, 2023) | ||
16-84410600-C-G | ATP2C2-related disorder | Benign (Apr 25, 2019) | ||
16-84410600-C-T | Likely benign (Aug 16, 2018) | |||
16-84410733-G-C | not specified | Uncertain significance (Nov 21, 2023) | ||
16-84410753-C-T | not specified | Uncertain significance (Jan 30, 2024) | ||
16-84415491-A-G | not specified | Uncertain significance (Sep 12, 2023) | ||
16-84415502-C-G | not specified | Uncertain significance (Mar 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ATP2C2 | protein_coding | protein_coding | ENST00000262429 | 27 | 95661 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.02e-60 | 5.09e-14 | 122278 | 22 | 2541 | 124841 | 0.0103 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -5.59 | 950 | 573 | 1.66 | 0.0000357 | 6136 |
Missense in Polyphen | 469 | 276.56 | 1.6958 | 2851 | ||
Synonymous | -8.50 | 423 | 251 | 1.68 | 0.0000183 | 1887 |
Loss of Function | -3.44 | 75 | 49.0 | 1.53 | 0.00000243 | 578 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00981 | 0.00978 |
Ashkenazi Jewish | 0.00109 | 0.00109 |
East Asian | 0.00237 | 0.00234 |
Finnish | 0.0265 | 0.0263 |
European (Non-Finnish) | 0.0117 | 0.0116 |
Middle Eastern | 0.00237 | 0.00234 |
South Asian | 0.00949 | 0.00936 |
Other | 0.0114 | 0.0114 |
dbNSFP
Source:
- Function
- FUNCTION: This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the transport of calcium. {ECO:0000250}.;
- Pathway
- Vitamin D Receptor Pathway;Ion channel transport;Transport of small molecules;Ion transport by P-type ATPases
(Consensus)
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.113
- rvis_EVS
- -0.35
- rvis_percentile_EVS
- 29.6
Haploinsufficiency Scores
- pHI
- 0.145
- hipred
- hipred_score
- ghis
- 0.473
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.189
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Atp2c2
- Phenotype
Gene ontology
- Biological process
- cellular calcium ion homeostasis;calcium ion transmembrane transport;manganese ion transmembrane transport;ATP hydrolysis coupled cation transmembrane transport;proton transmembrane transport
- Cellular component
- Golgi membrane;integral component of membrane
- Molecular function
- calcium-transporting ATPase activity;protein binding;ATP binding;proton-exporting ATPase activity, phosphorylative mechanism;manganese-transporting ATPase activity;metal ion binding